Russia Considers Ban on E-cigarette Additives: Industry Voices Concerns

Aug.09.2023
Russia Considers Ban on E-cigarette Additives: Industry Voices Concerns
Russia's Health Ministry is set to introduce a bill prohibiting certain additives in e-cigarettes, including nicotine salts and flavorings.

In a press conference, Artyom Metchelyov, Chairman of the Youth Policy Committee of the State Duma of Russia, announced that the Russian Ministry of Health will soon submit a bill to the Russian Cabinet for review, which aims to ban the use of additives in e-cigarettes.


This list of substances banned from increasing the appeal of nicotine-containing liquids includes:


Food additives, herbal flavoring agents, and their derivatives, including vanillin, cocoa and its derivatives, licorice, spices, and any natural flavorings are prohibited. Synthetic sugars and synthetic or natural sweeteners are also prohibited. Additionally, additives that enhance nicotine addiction, such as nicotine salts, ethanol, ammonium, and ammonia, are banned.


According to a report from the Russian newspaper "News Report" on August 8th, the Russian Union of Nicotine-Containing Product Industry (Союз предприятий индустрии никотиносодержащих изделий, abbreviated as СПИНИ) and the Professional Alliance of Participants in the Russian Market of Electronic Nicotine Systems (Профессиональный альянс участников русского рынка электронных никотиновых систем, abbreviated as ПАУРРЭНС) have sent a letter to Russian Finance Minister Anton Siluanov, requesting the removal of food flavorings and salt-based nicotine from the list of banned substances and additives.


This letter has received support from over 50 industry professionals and experts in the e-cigarette sector. Among them is Lev Grigoriev, Chairman of BABYLON, a leading e-cigarette compliant distributor in Russia, who also opposes the policy change.


Lev Grigoriev stated:


Flavorings are used in all e-cigarette liquids, many of which are not noticeable. Many flavorings are processed using technology and without them, the product would be unusable. In other words, it is illogical to completely ban all flavorings as there is no similar situation in the world.


The Ministry of Health recommends exclusively using liquid products containing propylene glycol and glycerol, much like suggesting a complete ban on all types of alcohol such as wine, liquor, brandy, and so on, and only utilizing pure ethanol.


The second recommendation concerns nicotine salts. What are nicotine salts? From a chemical standpoint, they are simply nicotine. So why does the Ministry of Health believe they can be addictive? Addiction is not caused by nicotine itself, but rather by its concentration.


The recommendation from the Ministry of Health is unlikely to solve the problem it claims to address - reducing the accessibility of nicotine products for minors and teenagers. Examples of similar bans include snus, a tobacco product in Sweden. Although snus is still available on the market, it is supplied illegally without the payment of taxes. This significantly impacts consumers who may be exposed to low-quality and unsafe products. Similarly, if the use of nicotine salts and flavorings is prohibited, the situation would likely be comparable.


What are the recommendations from industry experts regarding the market? It is not to completely ban all flavors, as e-cigarettes are composed of various substances.


Taking into account that minors make up approximately 11.2% of all e-cigarette consumers, we are actively striving to restrict accessibility to underage individuals. However, under the current circumstances, this measure would affect around 90% of adult users.


References:


[1] The business sector has requested not to ban the use of flavorings in vaping products. [2] Vape sellers are requesting not to ban flavorings.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

India Steps Up Nicotine Pouch Enforcement as ZYN, White Fox Circulate and Drug Panel Urges Halt to New Nicotine Formulations
India Steps Up Nicotine Pouch Enforcement as ZYN, White Fox Circulate and Drug Panel Urges Halt to New Nicotine Formulations
India's Ministry of Health and Family Welfare has directed states to step up enforcement against nicotine pouch sales, citing increased availability through online and offline channels and concern about nicotine exposure among children. Reuters reported that international brands including ZYN and White Fox are being sold in India. A study led by ICMR-NICPR found pouches in seven of 10 surveyed locations and identified 68 brands and 445 flavors online. Separately, India's Drugs Technical Advisory Board recommended in August that no new nicotine formulation be approved.
Regulations
Sep.28 by 2Firsts Perspectives
Wisconsin Vape Directory One Year On: Retailer Reports Four Store Closures and 70% Staff Cuts
Wisconsin Vape Directory One Year On: Retailer Reports Four Store Closures and 70% Staff Cuts
Wisconsin's electronic vaping device directory has been fully enforced for more than a year, and local vape retailers say the reduced range of eligible products has contributed to declining sales, store closures and layoffs. Johnny Vapes owner Ben Hall said he has closed four of seven locations and cut about 70% of his staff. State law bars the sale of vaping devices not listed on the Wisconsin Department of Revenue directory and allows penalties of $1,000 per day for each unlisted device sold or offered for sale. In April 2026, the U.S. Court of Appeals for the Seventh Circuit allowed enforcement of the law to continue.
Regulations
Oct.10
Charlie’s Bets on Age-Gating and 678 PMTA Assets as U.S. Vape Enforcement Landscape Shifts
Charlie’s Bets on Age-Gating and 678 PMTA Assets as U.S. Vape Enforcement Landscape Shifts
Charlie’s Holdings said in its latest shareholder letter that it is moving to commercialize PACHA products and monetize its PMTA assets as the FDA changes enforcement priorities for unauthorized ENDS products. Thirty PACHA SKUs were previously tentatively identified for a proposed public list of products that the FDA generally does not intend to prioritize for enforcement. Charlie’s is also preparing test-market sales of age-gated flavored disposables and says it currently holds 678 PMTA-related product assets while seeking additional strategic transactions and partnerships.
Sep.11
R.J. Reynolds Vapor Company Launches Flavored Vuse Pro Pods in U.S. Without FDA Marketing Authorization
R.J. Reynolds Vapor Company Launches Flavored Vuse Pro Pods in U.S. Without FDA Marketing Authorization
R.J. Reynolds Vapor Company has begun selling four flavored Vuse Pro pods — Peach, Berry, Watermelon and Fresh Mint — in Ohio and selected other U.S. markets. According to the Vuse U.S. FAQ, Vuse Pro contains approximately 5.0% nicotine by weight, and Vuse Pro pre-filled pods are intended for use with Vuse Alto devices. Reynolds told 2Firsts that product labeling lists an e-liquid capacity of 2.0 mL per pod. The Vuse Alto Power Unit received FDA marketing authorization in 2024, while the new Vuse Pro pods themselves have not received marketing granted orders. The rollout follows the FDA’s May 2026 revision of enforcement priorities for certain unauthorized vaping products with qualifying pending applications.
BAT
Sep.10
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23
FDA Authorizes JUUL2, Cites Adult Switching Amid Efforts to Speed PMTA Reviews
FDA Authorizes JUUL2, Cites Adult Switching Amid Efforts to Speed PMTA Reviews
The FDA authorized the JUUL2 device and tobacco- and menthol-flavored pods on Aug. 28, bringing the number of authorized e-cigarette products to 48. The agency highlighted complete switching among adult smokers, with six-week switching rates reaching 28.4%–49.3% for the menthol pod. The decision comes as FDA works to speed PMTA reviews, reduce application backlogs and expand authorized e-cigarette and nicotine-pouch products while maintaining enforcement priorities for unauthorized products.
Regulations
Aug.29